Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Weich

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Cellular Oncology (Dordrecht, Netherlands)|June 16, 2025
Efficacy of CDK4/6 Inhibition in colorectal cancer and the role of p16 expression in predicting drug resistanceJulia S Schneider, Najib Ben Khaled, Liangtao Ye, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 22, 2023
CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell TumorsIngo Hartlapp, Philipp E Hartrampf, Sebastian E Serfling, et al.
The American Journal of Gastroenterology|March 13, 2025
International, Multicenter Analysis of Endoscopic Full-Thickness Resection of Duodenal Neuroendocrine TumorsAndreas Wannhoff, Zaheer Nabi, Leon M G Moons, et al.
JHEP Reports : Innovation in Hepatology|May 27, 2024
Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic eventsNajib Ben Khaled, Marie Möller, Leonie S Jochheim, et al.
JHEP Reports : Innovation in Hepatology|April 30, 2026
Multicenter study of bleeding and thromboembolic events with durvalumab tremelimumab vs. atezolizumab and bevacizumab in advanced HCCNajib Ben Khaled, Raphael Mohr, Leonie S Jochheim, et al.
JHEP Reports : Innovation in Hepatology|February 4, 2026
Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunityIgnazio Piseddu, Leonie S Jochheim, Katrin Boettcher, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Cellular Oncology (Dordrecht, Netherlands)|June 16, 2025
Efficacy of CDK4/6 Inhibition in colorectal cancer and the role of p16 expression in predicting drug resistanceJulia S Schneider, Najib Ben Khaled, Liangtao Ye, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 22, 2023
CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell TumorsIngo Hartlapp, Philipp E Hartrampf, Sebastian E Serfling, et al.
The American Journal of Gastroenterology|March 13, 2025
International, Multicenter Analysis of Endoscopic Full-Thickness Resection of Duodenal Neuroendocrine TumorsAndreas Wannhoff, Zaheer Nabi, Leon M G Moons, et al.
JHEP Reports : Innovation in Hepatology|May 27, 2024
Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic eventsNajib Ben Khaled, Marie Möller, Leonie S Jochheim, et al.
JHEP Reports : Innovation in Hepatology|April 30, 2026
Multicenter study of bleeding and thromboembolic events with durvalumab tremelimumab vs. atezolizumab and bevacizumab in advanced HCCNajib Ben Khaled, Raphael Mohr, Leonie S Jochheim, et al.
JHEP Reports : Innovation in Hepatology|February 4, 2026
Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunityIgnazio Piseddu, Leonie S Jochheim, Katrin Boettcher, et al.
Pageof 6